Regener8 and the Medical Technologies Innovation and Knowledge Centre (IKC) have awarded N8 Proof of Concept funding to Professor Paul Hatton from the School of Clinical Dentistry, Bioengineering and Health Technologies at the University of Sheffield.
The ‘Bioactive Cements and Pre-set Porous Scaffolds to Promote Bone Tissue Regeneration’ project will aim to prepare an innovative bone cement which can be used in situ with a pre-set porous scaffold to promote bone tissue regeneration, and will be carried out in partnership with Corinthian Surgical Ltd, a Nottingham-based company specialising in developing innovative biomaterials. The new technology could have applications in the treatment of conditions relating to the ear, as well as potential wider uses in the orthopaedics market as a bone graft substitute.
Launched in 2012 at a special event involving Iain Gray, Chief Executive of the Technology Strategy Board, the N8 POC awards provide exclusive funding for regenerative medicine projects that involve academic and industry collaborators. Funding is given to projects that align with the therapeutic priorities identified in the Research Councils UK (RCUK) Regenerative Medicine Strategy. The funding is provided by the Medical Technologies IKC (funded by the UK Research Councils, the Engineering and Physical Sciences Research Council (EPSRC) the Biotechnology and Biological Sciences Research Council (BBSRC), and the Technology Strategy Board) to accelerate and enhance innovation between academic and industry collaborators in projects that demonstrate significant commercial potential.
One further project, from the University of Manchester, has been approved subject to contract – further details are expected to be announced soon.